Russell Investments Group Ltd. Has $3.18 Million Stake in Pediatrix Medical Group, Inc. $MD

Russell Investments Group Ltd. raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 2.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 219,184 shares of the company’s stock after acquiring an additional 6,127 shares during the period. Russell Investments Group Ltd. owned about 0.26% of Pediatrix Medical Group worth $3,176,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Public Sector Pension Investment Board grew its holdings in shares of Pediatrix Medical Group by 27.3% in the 1st quarter. Public Sector Pension Investment Board now owns 268,076 shares of the company’s stock worth $3,884,000 after purchasing an additional 57,463 shares during the last quarter. Nuveen LLC acquired a new position in Pediatrix Medical Group in the first quarter valued at about $8,024,000. Invesco Ltd. grew its stake in Pediatrix Medical Group by 9.3% during the first quarter. Invesco Ltd. now owns 863,269 shares of the company’s stock worth $12,509,000 after buying an additional 73,157 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in Pediatrix Medical Group during the first quarter worth about $159,000. Finally, Natixis Advisors LLC increased its holdings in shares of Pediatrix Medical Group by 8.1% during the first quarter. Natixis Advisors LLC now owns 19,156 shares of the company’s stock worth $278,000 after buying an additional 1,435 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $16.9730 on Friday. The firm has a 50 day simple moving average of $13.76 and a 200 day simple moving average of $13.93. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.06 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The firm has a market cap of $1.48 billion, a P/E ratio of 13.16 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business’s quarterly revenue was down 7.1% compared to the same quarter last year. During the same period last year, the company earned $0.34 EPS. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on MD. Macquarie boosted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. UBS Group lifted their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Finally, Zacks Research raised Pediatrix Medical Group to a “strong-buy” rating in a research note on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.